Basics Avidity Biosciences, Inc. IPO Date: June 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $4B Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 3.31% Avg Daily Range (30 D): $0.96 | 3.15% Avg Daily Range (90 D): $0.96 | 3.22% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): 1.06M Avg Daily Volume (90 D): 1.21M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 2,188 Avg Inst. Trade: $2.71M Avg Inst. Trade (30 D): $2.92M Avg Inst. Trade (90 D): $2.86M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.6M Avg Closing Trade (30 D): $5.49M Avg Closing Trade (90 D): $5.92M Avg Closing Volume: 147.95K     News Jul 1, 2024 @ 5:38 PM Top Performing Industry ETFs In June: Software Lea... Source: Piero Cingari Jun 13, 2024 @ 2:39 PM Avidity (RNA) Up 33% on Rare Muscle Disease Study ... Source: Zacks Equity Research Jun 10, 2024 @ 12:01 PM A Glimpse Into The Expert Outlook On Avidity Biosc... Source: Benzinga Insights May 29, 2024 @ 12:45 PM 2 Potentially High-Reward Growth Stocks to Buy Rig... Source: newsfeedback@fool.com (George Budwell) May 9, 2024 @ 9:15 PM Coherus BioSciences (CHRS) Reports Q1 Loss, Misses... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.9 $-.65 Diluted EPS $-.9 $-.65 Revenue $ $ 1.57M $ 2.34M Gross Profit $ $ $ Net Income / Loss $ $ -115.77M $ -80.4M Operating Income / Loss $ $ -131.52M $ -98.13M Cost of Revenue $ $ $ Net Cash Flow $ $ 34.34M $ -205.56M PE Ratio